+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Age: 18Years +
All Genders
ID06386315

Phase 2 Randomized Trial of Reduced Dose Hypofractionated Radiation Therapy Versus Standard Radiation for Indolent Non-Hodgkin Lymphoma

Led by Mayo Clinic · Updated on 2026-04-22

112

Participants Needed

7

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating a phase II clinical trial comparing reduced dose radiation therapy to the standard dose in treating patients with indolent non-Hodgkin lymphoma. The study aims to assess whether lower doses of radiation, delivered in fewer treatment sessions, can reduce side effects while maintaining effectiveness. Indolent lymphoma is known to respond to radiation, but standard higher doses often cause more toxicities, so this trial explores if a reduced dose regimen is safer and still effective. Participants are randomly assigned to one of two groups. The experimental group receives involved-site radiation therapy ISRT at reduced doses of either 9 Gy in 3 fractions, 8 Gy in 2 fractions, or 10 Gy in 5 fractions, administered once daily excluding weekends. The comparison group receives the standard of care radiation therapy of 24 Gy in 12 fractions, also once daily excluding weekends. Both groups undergo imaging with CT or PETCT scans throughout the study, and may have endoscopy during screening and follow-up. During the study, patients are closely monitored with follow-up visits at days 7 and 14 after treatment, then at 3 and 6 months, and every 6 months up to 2 years post-radiation. Researchers evaluate acute side effects within 14 days after radiation, response rates, local tumor control, relapse-free survival, quality of life, financial impact, and late toxicities. Biopsies and advanced imaging analyses are performed to study disease characteristics and treatment response. Patients complete questionnaires and are followed for safety and disease progression during the study period.

CONDITIONS

Brief Title

Reduced Dose Radiotherapy for the Treatment of Indolent Non-Hodgkin Lymphoma

Research Team

C

Clinical Trials Referral Office

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here